Tag: Gilead

ACT – One Step Closer to Accessing PrEP in Canada

HIV prevention in Canada took a significant step forward today when pharmaceutical company Gilead Sciences Canada announced it is seeking approval for the use of Truvada as Pre Exposure Prophylaxis in Canada. The onus now sits with Health Canada and policy makers to ensure universal access and coverage of PrEP. Truvada used as PrEP is… Read more »